The effect of pregnancy on cyclosporine levels in renal allograft patients

被引:31
作者
Thomas, AG
Burrows, L
Knight, R
Panico, M
Lapinski, R
Lockwood, CJ
机构
[1] MT SINAI SCH MED,DEPT OBSTET GYNECOL & REPROD SCI,NEW YORK,NY
[2] MT SINAI SCH MED,DEPT SURG,DIV ABDOMINAL TRANSPLANTAT,NEW YORK,NY
[3] NYU,SCH MED,DEPT OBSTET & GYNECOL,NEW YORK,NY
关键词
D O I
10.1016/S0029-7844(97)00535-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To assess the effects of pregnancy on cyclosporine levels in six renal allograft patients. Methods: Maternal demographic, laboratory, clinical, and perinatal outcome data were recorded in six pregnant women with previous renal allografts receiving cyclosporine immunosuppression. The cyclosporine and serum creatinine levels were measured before pregnancy, during each trimester, and postpartum. Results: The mean (standard deviation [SD]) maternal age was 29.1 (3.8) years. Parity ranged from 9 to 3. Mean serum creatinine levels tended to be lower during pregnancy than before or after, as did the mean cyclosporine levels. After adjusting for dose, five of six patients had declines in cyclosporine level during pregnancy. The mean (SD) gestational age at delivery was 37.5 (2.8) weeks with a mean (SD) birth weight of 2837 (538) g. Conclusion: Pregnancy in patients with renal allografts can lead to a substantial decline in cyclosporine levels. (C) 1997 by The American College of Obstetricians and Gynecologists.
引用
收藏
页码:916 / 919
页数:4
相关论文
共 14 条
[1]  
ARMENTI VT, 1994, TRANSPLANTATION, V57, P502
[2]  
BIESENBACH G, 1989, NEPHROL DIAL TRANSPL, V4, P667
[3]  
Bumgardner GL, 1992, TRANSPLANT REV, V6, P139
[4]   ANTIEPILEPTIC DRUGS - METABOLISM IN PREGNANCY [J].
DAM, M ;
CHRISTIANSEN, J ;
MUNCK, O ;
MYGIND, KI .
CLINICAL PHARMACOKINETICS, 1979, 4 (01) :53-62
[5]  
DAVIS M, 1973, J OBSTET GYN BR COMM, V80, P690
[6]   DIALYSIS, TRANSPLANTATION, AND PREGNANCY [J].
DAVISON, JM .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (02) :127-132
[7]  
DERFLER K, 1988, CLIN NEPHROL, V29, P96
[8]   SUCCESSFUL PREGNANCY IN A RENAL-TRANSPLANT RECIPIENT TAKING CYCLOSPORINE-A [J].
DUGGAN, CJ ;
BOYCE, ES ;
CATERSON, RJ ;
MAHONY, JF .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (06) :813-814
[9]   THE PRESENCE OF CYCLOSPORINE IN BODY-TISSUES AND FLUIDS DURING PREGNANCY [J].
FLECHNER, SM ;
KATZ, AR ;
ROGERS, AJ ;
VANBUREN, C ;
KAHAN, BD .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1985, 5 (01) :60-63
[10]   EFFECTS OF PLASMA-LIPID LEVELS ON BLOOD DISTRIBUTION AND PHARMACOKINETICS OF CYCLOSPORINE-A [J].
GARDIER, AM ;
MATHE, D ;
GUEDENEY, X ;
BARRE, J ;
BENVENUTTI, C ;
NAVARRO, N ;
VERNILLET, L ;
LOISANCE, D ;
CACHERA, JP ;
JACOTOT, B ;
TILLEMENT, JP .
THERAPEUTIC DRUG MONITORING, 1993, 15 (04) :274-280